Transcranial magnetoelectric depression therapeutic apparatus

Abstract

The invention provides a trabscranial magnetoelectric depression therapeutic apparatus, comprising a pair of earphones, a beam connected between the earphones, at least a magnet, at least a pair of electrodes and an internal circuit; wherein, the earphones and the electrodes are connected with the internal circuit. The technical proposal is as follows: trabscranial magnetoelectricity and audio signals directly act on heads and auditory systems of human; stereo superposition electric field formed in certain parts of brain by trabscranial magnet can ensure the parts to generate weak induced current so as to self stimulate the parts to secrete dopamine and restore the function of self secreting neurotransmitter such as dopamine by the parts; the trabscranial magnet directly stimulates neutral clusters of basal ganglia of thalamus, thus strengthening the effects of the trabscranial magnet; the audio signals with special rhythm act on the auditory systems of human, which can promote human to enter into meditation and tempt secretion of the neurotransmitter such as dopamine in the brain, thus further strengthening the effects of the trabscranial magnet. The trabscranial magnetoelectricity and audio signals integrate three effects into one, supplement and complement each other and promote each other, and the therapeutic effect on depression and insomnia is unreachable for any single function.

Description

1. Technical field [0001] The invention relates to a transcranial magnetoelectric treatment device for depression, in particular to a treatment device for preventing and treating depression, insomnia, neurasthenia and other diseases. 2. Background technology [0002] Depression refers to a certain unpleasant state of mind and dysfunction of certain body organs, and its degree can range from mild sadness to severe despair, suicide attempt, etc. It is a common psychopathological state or syndrome, the main cause of which is There are many causes, such as social and environmental factors, genetic factors, drug factors, physical diseases and personality qualities, etc., because of these inducements, the central nervous system norepinephrine (noradrenaline, NA) and 5-hydroxytryptamine, dopamine and other monoamines are triggered. The level of neurotransmitters is too low and the function of their receptors is low, thus showing many clinical symptoms as mentioned above. Depression...

AI Technical Summary

Problems solved by technology

[0002] Depression refers to a certain unpleasant state of mind and dysfunction of certain body organs, and its degree can range from mild sadness to severe despair, suicide attempt, etc. It is a common psychopathological state or syndrome, the main cause of which is There are many causes, such as social and environmental factors, genetic factors, drug factors, physical diseases and personality qualities, etc., because of these inducements, the central nervous system norepinephrine (noradrenaline, NA) and 5-hydroxytryptamine, dopamine and other monoamines are triggered. The level of neurotransmitters is too low and the function of their receptors is low, thus showing many clinical symptoms as mentioned above. Depression has the characteristics of high incidence and wide age of onset, which has seriously affected people's work and life .At present, depression has become an important mental and psychological disease of global concern. Early detection and early treatment of depression can prevent irreversible damage to the central nervous system. At present, drug treatment and psychotherapy are mainly used clinically. Or when the patient is unable to take medicine, electroconvulsive therapy can also be used. However, drug therapy has the disadvantages of long-term medication and side effects. Electroshock therapy also has its physiological side effects. Psychotherapy is limited by economic conditions due to its high cost. There is no better and effective solution to these problems

Images